Mesenchymal stem cells (MSC) prevented the progression of renovascular hypertension, improved renal function and architecture.
Renovascular hypertension induced by 2 Kidney-1 Clip (2K-1C) is a renin-angiotensin-system (RAS)-dependent model, leading to renal vascular rarefaction and renal failure. RAS inhibitors are not able to reduce arterial pressure (AP) and/or preserve the renal function, and thus, alternative therapies...
Main Authors: | Elizabeth B Oliveira-Sales, Edgar Maquigussa, Patricia Semedo, Luciana G Pereira, Vanessa M Ferreira, Niels O Câmara, Cassia T Bergamaschi, Ruy R Campos, Mirian A Boim |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3817204?pdf=render |
Similar Items
-
Treatment with Mesenchymal Stem Cells Improves Renovascular Hypertension and Preserves the Ability of the Contralateral Kidney to Excrete Sodium
by: Vanessa Araujo Varela, et al.
Published: (2019-10-01) -
Chronic Nicotine Exposure Abolishes Maternal Systemic and Renal Adaptations to Pregnancy in Rats.
by: Vanessa Meira Ferreira, et al.
Published: (2016-01-01) -
Renal artery stenosis and development of renovascular hypertension
by: Anderson Martelli
Published: (2014-06-01) -
Role of the Rostral Ventrolateral Medulla in the Arterial Hypertension in Chronic Renal Failure
by: Adriana P. Castilho Dugaich, et al.
Published: (2010-01-01) -
Renovascular hypertension in children
by: Premal Amrishkumar Patel, et al.
Published: (2021-01-01)